Psilocin and Psilocybin in Canada are both classified as Schedule lll drugs under Canada’s Controlled Drugs and Substances Act(CDSA). After all, he sells mushrooms from a website: Similar to cannabis compassion clubs that served medical cannabis consumers prior to legalization, he sells microdoses of psilocybin to Canadians who can provide medical documentation with qualifying diagnoses.
Other emerging research is showing the potential of psychedelics, some of which have been granted breakthrough therapy” status by the U.S. magic mushrooms canada Food and Drug Administration, to possibly treat and cure a range of medical concerns from Alzheimer’s to depression to addiction.
In 2017, Tobin submitted an application to Health Canada requesting a special exemption to the current drug laws that would allow him to procure synthetic psilocybin and provide it to a group of terminal cancer patients who are experiencing end-of-life distress for which other treatments haven’t worked.
One big issue with magic mushrooms is that there are a number of poisonous mushroom species which may appear very similar to the magic mushrooms, and each year in Canada and the USA there are reports of people eating a poisonous mushroom in an attempt to get high.
These preliminary results show that “in the right context, these drugs can help people a lot, especially people who have disorders that we generally treat poorly, such as end-of-life distress, PTSD, and addiction issues involving tobacco or alcohol,” said study co-author Matthew Johnson.
However, when a follow-up question was asked, prefaced by this incontrovertible information: Recent clinical studies have shown that psilocybin – the psychedelic compound found in magic mushrooms – has helped treat end-of-life distress for terminally ill patients….”, Canadians strongly responded with a 59% approval rating of this currently illegal treatment option.
Researchers at Johns Hopkins University, the Multidisciplinary Association for Psychedelic Substances (MAPS) and other leading researchers have published studies showing the benefits of psilocybin in treating Post-Traumatic Stress Disorder (PTSD) and other mental health issues.
In one U.S. study published in the Journal of Psychopharmacology in January, patients with cancer-related psychiatric distress continued to experience reductions in anxiety, depression, hopelessness, demoralization, and death anxiety more than four years after a single dose of psilocybin in combination with psychotherapy.
For those interested in learning more, check out The Mushroom Dispensary’s website here Larsen is hopeful that the Canadian courts will recognize the medicinal value of psilocybin in the same way that it did for cannabis in the lead up to legalization.